| Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis F Ciccia, G Guggino, A Rizzo, L Saieva, S Peralta, AR Giardina, ... Annals of the rheumatic diseases 74 (9), 1739-1747, 2015 | 298 | 2015 |
| Overexpression of interleukin‐23, but not interleukin‐17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis F Ciccia, M Bombardieri, A Principato, AR Giardina, C Tripodo, R Porcasi, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 274 | 2009 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 196 | 2012 |
| Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut … F Ciccia, A Accardo-Palumbo, A Rizzo, G Guggino, S Raimondo, ... Annals of the rheumatic diseases 73 (8), 1566-1574, 2014 | 188 | 2014 |
| Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome F Ciccia, G Guggino, A Rizzo, A Ferrante, S Raimondo, AR Giardina, ... Annals of the rheumatic diseases 71 (2), 295-301, 2012 | 177 | 2012 |
| Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis F Ciccia, A Accardo‐Palumbo, R Alessandro, A Rizzo, S Principe, ... Arthritis & Rheumatism 64 (6), 1869-1878, 2012 | 141 | 2012 |
| IL-34 is overexpressed in the inflamed salivary glands of patients with Sjögren’s syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16 … F Ciccia, R Alessandro, V Rodolico, G Guggino, S Raimondo, ... Rheumatology 52 (6), 1009-1017, 2013 | 134 | 2013 |
| Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ... The Journal of rheumatology 39 (6), 1179-1184, 2012 | 130 | 2012 |
| One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugs AR Giardina, A Ferrante, F Ciccia, M Vadalà, E Giardina, G Triolo Rheumatology international 31, 33-37, 2011 | 82 | 2011 |
| IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis F Ciccia, R Alessandro, A Rizzo, S Raimondo, AR Giardina, F Raiata, ... Annals of the rheumatic diseases 72 (2), 258-264, 2013 | 75 | 2013 |
| Expansion of intestinal CD4+CD25high Treg cells in patients with ankylosing spondylitis: A putative role for interleukin‐10 in preventing intestinal Th17 response F Ciccia, A Accardo‐Palumbo, AR Giardina, P Di Maggio, A Principato, ... Arthritis & Rheumatism 62 (12), 3625-3634, 2010 | 71 | 2010 |
| Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis F Ciccia, R Alessandro, A Rizzo, A Accardo-Palumbo, S Raimondo, ... Rheumatology 53 (1), 104-113, 2014 | 65 | 2014 |
| Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial F Iannone, G La Montagna, G Bagnato, E Gremese, AR Giardina, ... The Journal of Rheumatology 41 (2), 286-292, 2014 | 62 | 2014 |
| A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis AR Giardina, A Ferrante, F Ciccia, R Impastato, MC Miceli, A Principato, ... Rheumatology international 30, 1437-1440, 2010 | 58 | 2010 |
| Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima–media thickness in female patients with active rheumatoid arthritis A Ferrante, AR Giardina, F Ciccia, G Parrinello, G Licata, G Avellone, ... Rheumatology international 30, 193-198, 2009 | 58 | 2009 |
| The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-10 producing Th17 … G Guggino, A Giardina, A Ferrante, G Giardina, C Schinocca, G Sireci, ... Rheumatology International 35, 171-175, 2015 | 54 | 2015 |
| Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome F Ciccia, G Guggino, A Rizzo, R Alessandro, F Carubbi, AR Giardina, ... Rheumatology 53 (7), 1313-1320, 2014 | 54 | 2014 |
| Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation F Ciccia, M Bombardieri, A Rizzo, A Principato, AR Giardina, F Raiata, ... Rheumatology 49 (11), 2076-2083, 2010 | 53 | 2010 |
| Expression of interleukin‐32 in the inflamed arteries of patients with giant cell arteritis F Ciccia, R Alessandro, A Rizzo, S Principe, F Raiata, A Cavazza, ... Arthritis & Rheumatism 63 (7), 2097-2104, 2011 | 46 | 2011 |
| Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion G Guggino, AR Giardina, S Raimondo, G Giardina, G Sireci, F Dieli, ... Clin Exp Rheumatol 32 (1), 77-81, 2014 | 40 | 2014 |
